- Profil
- Réseaux sociaux
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Top-tier venture capital practice that is our preferred choice for any UK deal. The team has great knowledge of the latest trends and market practices, while being pragmatic and not shy to recommend a way forward, which ensures a high degree of deal certainty.’
‘Ross McNaughton and Oli Denne. They both have solid commercial acumen and an ability to distil the negotiation dynamics into clear recommendations of how to quickly find a way forward. While having our best interest in mind, they are great at project managing transactions, keeping stakeholders informed and aligned - also when representing a syndicate of multiple investors.’
‘Extremely deep knowledge about the international biotech space. Experts in both licensing, fund raising and M&A. Pragmatic, realistic, and bridge builders. Particularly strong with academic and university led spin outs and managing expectations and inexperience that lead to a fair consensus.’
Clients clés
- Apollo Therapeutics
- Nuclera
- CamenaBio
- Tagomics
- Infinitopes
- Alveogene
- 2150
- Lingotto
- Multiomic Health
- CodingBio
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Responsable de la pratique
Ross McNaughton
Autres avocats clés
Adrian Toutoungi; Oli Denne